The Biobank Integrating Longitudinal ERCP Within a Prospective Chronic Pancreatitis Cohort

Sponsor
First People's Hospital of Hangzhou
Study ID
NCT07770412
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • This observational cohort study does not involve any interventions — OTHER
    This observational cohort study does not involve any interventions

Study Details

The Biobank Integrating Longitudinal ERCP within a Prospective Chronic Pancreatitis Cohort (BILE-CP) is a prospective longitudinal cohort study conducted in Hangzhou, Zhejiang Province, China. The study plans to consecutively enroll 1,500 patients with chronic pancreatitis for long-term follow-up (scheduled every 6 months). This cohort encompasses patients across the entire disease course of chronic pancreatitis, with a particular focus on and in-depth tracking of a sub-cohort of patients undergoing ERCP treatments. During baseline and follow-up visits, researchers will collect multidimensional data from participants, including sociodemographics, diet and lifestyle, emotional status and sleep quality, clinical phenotypes and disease characteristics, ERCP intervention details, clinical laboratory and imaging examinations, continuous glucose monitoring (CGM), and traditional Chinese medicine indicators. Concurrently, multi-site biological samples will be collected, including but not limited to blood, feces, bile, saliva, tongue coating, and urine.

Key Dates

First listed
Aug 18, 2026
Start date
Aug 15, 2026
Status verified
Aug 2026
Primary completion
Jan 31, 2031
Completion
Aug 31, 2031

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: BILE-CP Cohort: Patients with Chronic Pancreatitis Meeting Inclusion and Exclusion Criteria
    All eligible patients clinically diagnosed with chronic pancreatitis and receiving standard clinical treatment at the research center. This observational cohort study excludes interventions. And the primary clinical exposure factors of interest include ERCP, lifestyle, and the use of traditional Chinese medicine and herbal remedies.

Primary Outcome Measure

Changes in Exocrine Functions [ Time Frame: Six months ]

Central Contacts

Related Studies